Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Apr 26, 2005

30339_dirs_2005-04-26_d74d2c81-7859-43fc-b590-2a611d3835c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-04-22

Reporting Person: ELLERS STEVEN A (Pres., Pharma. Systems Div.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-04-22 Common Stock A 13.49 $26.6100 Acquired 16187.7918 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 89969.2812 Direct
Common Stock 2770.8023 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.